1. Home
  2. BMY

BMY

Bristol-Myers Squibb Company

Logo Bristol-Myers Squibb Company

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-12-2024 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.

Founded: 1887 Country:
United States
United States
Employees: N/A City: PRINCETON
Market Cap: 103.6B IPO Year: N/A
Target Price: $60.75 AVG Volume (30 days): 16.1M
Analyst Decision: Hold Number of Analysts: 17
Dividend Yield: 4.95% Dividend Payout Frequency: Quarterly
EPS: 3.86 EPS Growth: 30.85
52 Week Low/High: $47.58 - $70.94 Next Earning Date: 04-25-2024
Revenue: $45,006,000,000 Revenue Growth: -2.50%
Revenue Growth (this year): 3.18% Revenue Growth (next year): 0.94%

Share on Social Networks: